Review



primary antibodies phf2  (Bioss)


Bioz Verified Symbol Bioss is a verified supplier
Bioz Manufacturer Symbol Bioss manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Bioss primary antibodies phf2
    Primary Antibodies Phf2, supplied by Bioss, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies phf2/product/Bioss
    Average 90 stars, based on 1 article reviews
    primary antibodies phf2 - by Bioz Stars, 2026-05
    90/100 stars

    Images



    Similar Products

    primary antibodies phf2  (Bioss)
    90
    Bioss primary antibodies phf2
    Primary Antibodies Phf2, supplied by Bioss, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies phf2/product/Bioss
    Average 90 stars, based on 1 article reviews
    primary antibodies phf2 - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    phf2 primary antibody  (Cell Signaling Technology Inc)
    93
    Cell Signaling Technology Inc phf2 primary antibody
    The synthesis and therapeutic process. Notes: ( A ) The synthesis procedure of <t>IPPD-PHF2.</t> ( B ) Tumor-targeting gene-drug-combined PLGA nanoparticle, termed as IPPD-PHF2, was engineered to integrate epigenetic regulation and chemotherapy to induce MET, amplify the inhibition of tumor metastasis and proliferation, and work as a potential PA/FL imaging probe.
    Phf2 Primary Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/phf2 primary antibody/product/Cell Signaling Technology Inc
    Average 93 stars, based on 1 article reviews
    phf2 primary antibody - by Bioz Stars, 2026-05
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    The synthesis and therapeutic process. Notes: ( A ) The synthesis procedure of IPPD-PHF2. ( B ) Tumor-targeting gene-drug-combined PLGA nanoparticle, termed as IPPD-PHF2, was engineered to integrate epigenetic regulation and chemotherapy to induce MET, amplify the inhibition of tumor metastasis and proliferation, and work as a potential PA/FL imaging probe.

    Journal: International Journal of Nanomedicine

    Article Title: Inhibited Metastasis and Amplified Chemotherapeutic Effects by Epigene-Transfection Based on a Tumor-Targeting Nanoparticle

    doi: 10.2147/IJN.S247567

    Figure Lengend Snippet: The synthesis and therapeutic process. Notes: ( A ) The synthesis procedure of IPPD-PHF2. ( B ) Tumor-targeting gene-drug-combined PLGA nanoparticle, termed as IPPD-PHF2, was engineered to integrate epigenetic regulation and chemotherapy to induce MET, amplify the inhibition of tumor metastasis and proliferation, and work as a potential PA/FL imaging probe.

    Article Snippet: PHF2 primary antibody was purchased from Cell Signaling Technology (USA).

    Techniques: Inhibition, Imaging

    Characterization of the nanoparticles. Notes: ( A ) SEM and TEM images of IPPD NPs and IPPD-PHF2 NPs (scale bars: TEM=100nm, SEM=200nm). The red arrows represented the plasmids adsorbed onto the surface of IPPD NPs, while the blue arrows represented the IPPD NPs. ( B ) Size distribution of IPPD-PHF2 NPs and zeta potential of PD, IPD, IPPD and IPPD-PHF2 NPs. ( C ) Safety concentrations of IPP NPs. ( D ) Standard curve of IR780 concentration, regression equation: Y=8.205X+0.0677, R square=0.9927, embedding rate of IR780≈16.5%. ( E ) Adsorption between IPPD NPs and PHF2, green: Doxorubicin, red: PHF2 dyed by Gel-Red. ( F ) Covalent binding between branched PEI and PLGA measured by FTIR, peak A: the typical double peaks range from 3400cm −1 to 3520cm −1 , peak B: the significant peak of primary amine in amido bond ranges from 1600cm −1 to 1640cm −1 .

    Journal: International Journal of Nanomedicine

    Article Title: Inhibited Metastasis and Amplified Chemotherapeutic Effects by Epigene-Transfection Based on a Tumor-Targeting Nanoparticle

    doi: 10.2147/IJN.S247567

    Figure Lengend Snippet: Characterization of the nanoparticles. Notes: ( A ) SEM and TEM images of IPPD NPs and IPPD-PHF2 NPs (scale bars: TEM=100nm, SEM=200nm). The red arrows represented the plasmids adsorbed onto the surface of IPPD NPs, while the blue arrows represented the IPPD NPs. ( B ) Size distribution of IPPD-PHF2 NPs and zeta potential of PD, IPD, IPPD and IPPD-PHF2 NPs. ( C ) Safety concentrations of IPP NPs. ( D ) Standard curve of IR780 concentration, regression equation: Y=8.205X+0.0677, R square=0.9927, embedding rate of IR780≈16.5%. ( E ) Adsorption between IPPD NPs and PHF2, green: Doxorubicin, red: PHF2 dyed by Gel-Red. ( F ) Covalent binding between branched PEI and PLGA measured by FTIR, peak A: the typical double peaks range from 3400cm −1 to 3520cm −1 , peak B: the significant peak of primary amine in amido bond ranges from 1600cm −1 to 1640cm −1 .

    Article Snippet: PHF2 primary antibody was purchased from Cell Signaling Technology (USA).

    Techniques: Zeta Potential Analyzer, Concentration Assay, Adsorption, Binding Assay

    Tests for properties. Notes: ( A ) Adsorption rate of IPPD NPs detected by FCM, PHF2 were stained with Gel-Red, sample 0 and 1 were treated without PHF2 incubation. Sample 2, 3, 4 represented experimental groups incubated with PHF2 for 5min, 10min and 60min, respectively. ( B ) Quantification of adsorption capacity. ( C ) Comparison of NP-uptake between IPPD NPs and PPD NPs, bar scale=50um. ( D ) Standard curve of Dox concentration. ( E ) Drug release curve of IPPD NPs.

    Journal: International Journal of Nanomedicine

    Article Title: Inhibited Metastasis and Amplified Chemotherapeutic Effects by Epigene-Transfection Based on a Tumor-Targeting Nanoparticle

    doi: 10.2147/IJN.S247567

    Figure Lengend Snippet: Tests for properties. Notes: ( A ) Adsorption rate of IPPD NPs detected by FCM, PHF2 were stained with Gel-Red, sample 0 and 1 were treated without PHF2 incubation. Sample 2, 3, 4 represented experimental groups incubated with PHF2 for 5min, 10min and 60min, respectively. ( B ) Quantification of adsorption capacity. ( C ) Comparison of NP-uptake between IPPD NPs and PPD NPs, bar scale=50um. ( D ) Standard curve of Dox concentration. ( E ) Drug release curve of IPPD NPs.

    Article Snippet: PHF2 primary antibody was purchased from Cell Signaling Technology (USA).

    Techniques: Adsorption, Staining, Incubation, Comparison, Concentration Assay

    Gene transfection in vitro. Notes: ( A ) Expression of EGFP after transfection. ( B ) Western Blotting results of expression level changes of PHF2 and related proteins after transfection, and the corresponding gray value intensity analysis. ( C ) Verification of expression level changes of ERα/Cx43 by immunofluorescence.

    Journal: International Journal of Nanomedicine

    Article Title: Inhibited Metastasis and Amplified Chemotherapeutic Effects by Epigene-Transfection Based on a Tumor-Targeting Nanoparticle

    doi: 10.2147/IJN.S247567

    Figure Lengend Snippet: Gene transfection in vitro. Notes: ( A ) Expression of EGFP after transfection. ( B ) Western Blotting results of expression level changes of PHF2 and related proteins after transfection, and the corresponding gray value intensity analysis. ( C ) Verification of expression level changes of ERα/Cx43 by immunofluorescence.

    Article Snippet: PHF2 primary antibody was purchased from Cell Signaling Technology (USA).

    Techniques: Transfection, In Vitro, Expressing, Western Blot, Immunofluorescence

    Anti-cancer effects of PHF2. Notes : ( A ) Wound healing assay. The difference of width in transfection group between Day3 and Day1 showed no significance, p>0.9999, while the data in control group showed significance, p=0.0003. The widths of the wounds in day 1 and day 3 were compared by t -test. ( B ) Cell morphology change. ( C ) Comparison of cytotoxicity between IPP NPs and Lipo2000 via t -test (ns: non-significance, *p<0.05, **p<0.01, ***p<0.001). ( D ) Enhanced drug sensitivity of MDA-MB-231 after transfection, 1-EGFP and 4-EGFP were proportions of EGFP-expressing cells in group1 and group4, respectively.

    Journal: International Journal of Nanomedicine

    Article Title: Inhibited Metastasis and Amplified Chemotherapeutic Effects by Epigene-Transfection Based on a Tumor-Targeting Nanoparticle

    doi: 10.2147/IJN.S247567

    Figure Lengend Snippet: Anti-cancer effects of PHF2. Notes : ( A ) Wound healing assay. The difference of width in transfection group between Day3 and Day1 showed no significance, p>0.9999, while the data in control group showed significance, p=0.0003. The widths of the wounds in day 1 and day 3 were compared by t -test. ( B ) Cell morphology change. ( C ) Comparison of cytotoxicity between IPP NPs and Lipo2000 via t -test (ns: non-significance, *p<0.05, **p<0.01, ***p<0.001). ( D ) Enhanced drug sensitivity of MDA-MB-231 after transfection, 1-EGFP and 4-EGFP were proportions of EGFP-expressing cells in group1 and group4, respectively.

    Article Snippet: PHF2 primary antibody was purchased from Cell Signaling Technology (USA).

    Techniques: Wound Healing Assay, Transfection, Control, Comparison, Expressing

    Immunohistochemical detection. Notes: ( A ) IHC results of PHF2/E-cadherin/Vimentin expression in tumor tissues. ( B ) Comparison of PHF2 expression levels in liver/lung between normal nude mice and nude mice treated with IPP-PHF2 NPs.

    Journal: International Journal of Nanomedicine

    Article Title: Inhibited Metastasis and Amplified Chemotherapeutic Effects by Epigene-Transfection Based on a Tumor-Targeting Nanoparticle

    doi: 10.2147/IJN.S247567

    Figure Lengend Snippet: Immunohistochemical detection. Notes: ( A ) IHC results of PHF2/E-cadherin/Vimentin expression in tumor tissues. ( B ) Comparison of PHF2 expression levels in liver/lung between normal nude mice and nude mice treated with IPP-PHF2 NPs.

    Article Snippet: PHF2 primary antibody was purchased from Cell Signaling Technology (USA).

    Techniques: Immunohistochemical staining, Expressing, Comparison

    Anti-cancer effects in vivo. Notes: ( A ) Photos of MDA-MB-231 tumor-bearing nude mice captured during the 20-day treating process and photos of tumors at the end of treatments. ( B ) Tumor growth curve and weight changes of the mice. The difference of tumor volume between Day20 and Day1 in the IPPD-PHF2 group showed no significance, p=0.1793, while in other groups, the difference was significant at various levels. The difference of mice weight between Day20 and Day1 in control group, IPP group and IPPD-PHF2 group showed no significance, the p-value was 0.5987, 0.4061, and 0.5948, respectively. Data in day20 and day1 were compared by t -test (ns: non-significance, *p<0.05, **p<0.01).

    Journal: International Journal of Nanomedicine

    Article Title: Inhibited Metastasis and Amplified Chemotherapeutic Effects by Epigene-Transfection Based on a Tumor-Targeting Nanoparticle

    doi: 10.2147/IJN.S247567

    Figure Lengend Snippet: Anti-cancer effects in vivo. Notes: ( A ) Photos of MDA-MB-231 tumor-bearing nude mice captured during the 20-day treating process and photos of tumors at the end of treatments. ( B ) Tumor growth curve and weight changes of the mice. The difference of tumor volume between Day20 and Day1 in the IPPD-PHF2 group showed no significance, p=0.1793, while in other groups, the difference was significant at various levels. The difference of mice weight between Day20 and Day1 in control group, IPP group and IPPD-PHF2 group showed no significance, the p-value was 0.5987, 0.4061, and 0.5948, respectively. Data in day20 and day1 were compared by t -test (ns: non-significance, *p<0.05, **p<0.01).

    Article Snippet: PHF2 primary antibody was purchased from Cell Signaling Technology (USA).

    Techniques: In Vivo, Control